B Group, Inc.
SEC insider (Form 3/4/5 filer). CIK 0002043476. 10% Owner at Retension Pharmaceuticals, Inc. (RTSN) and 1 other issuer. 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in DALLAS, TX.
Companies B Group, Inc. has filed insider reports for
- Retension Pharmaceuticals, Inc. (RTSN): 10% Owner
- NRX Pharmaceuticals, Inc. (NRXP): 10% Owner
B Group, Inc.
CIK: 0002043476
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (0 total)
2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 2 Form 3 filings on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions